
Q&A: A pet food startup founder brings a pharmaceutical approach to fresh food
Irene Ou, founder of Purely Golden Foods, explains what her pharmaceutical background revealed about the gap between pet food claims and finished-product evidence, how the pet food startup defines clinical-grade nutrition, and what its 8-week Cornell feeding evaluation found.
Veterinarians are fielding more client questions about fresh food diets, a category in which marketing terms such as "fresh" and "human-grade" are not universally tied to finished-product clinical validation. Purely Golden Foods, a Boston, Massachusetts-based company that launched in April 2026 with a subscription fresh food line formulated exclusively for dogs under 20 lb, has positioned itself around what it calls clinical-grade nutrition, a self-designated term that does not correspond to a regulatory designation or independently verified standard,
Irene Ou, founder of Purely Golden Foods, came to pet nutrition from pharmaceutical finance and supply chain, where a product moves forward only after meeting predefined specifications verified through testing. In this Q&A, Ou explains why she sees the industry's most meaningful gap as the space between what brands claim and what they can objectively substantiate. She also discusses how that view shaped the company's approach, including veterinary nutritionist oversight, batch-level nutrient testing, and early findings from an 8-week controlled feeding evaluation at Cornell University. Study findings described in this Q&A are company reported and had not been peer reviewed at the time of the interview.
Editor's note: This dvm360 Q&A has been edited and consolidated from a verbal interview conducted in June 2026 to better fit a written format while retaining the substance of the original conversation.
dvm360: Can you introduce yourself and your background?
Ou: My name is Irene Ou, and I'm the founder of Purely Golden Foods. One thing becoming a parent has reinforced for me is how much long-term health is influenced by everyday decisions. Nutrition is just one of those decisions, and that idea ultimately led to Purely Golden Foods.
We wanted to bring a more evidence-oriented approach to pet nutrition, combining veterinary formulation oversight, batch testing, and research-backed evaluation of the finished food.
dvm360: Purely Golden Foods describes itself as offering clinical-grade nutrition. How do you define that phrase, and what standards does a product have to meet?
Ou: For us, clinical grade means applying principles that are common in evidence-based health care: measurable inputs, standardized processes, objective monitoring, and continuous validation.
That starts with formulation oversight from a board-certified veterinary nutritionist. Every recipe is formulated to meet established canine nutrient requirements, and we verify nutrient components through batch-level testing rather than relying solely on formulation software or formulation [on] paper. The goal is to confirm what is actually in the finished food that the dog consumes.
It also means evaluating the food itself, not just ingredients. Nutrition science ultimately has to be assessed at the level of the finished diet, because ingredient quality, processing, digestibility, and nutrient interactions all influence the final nutritional outcome.
The third component is generating objective data. Our launch is supported by a controlled feeding evaluation with Cornell University that's examining digestive and physiological outcomes, including stool quality, microbiome measures, inflammatory biomarkers, body condition, and other health indicators. We believe nutritional decisions should be informed by evidence rather than assumptions alone, and this aligns with a broader principle in nutrition science that conclusions should be based on the totality of available evidence and measured biological responses.
So when we say clinical grade, we mean nutrition developed with veterinary expertise, verified through testing, and supported by objective evaluations of the finished food.
dvm360: Your background is in pharma finance rather than veterinary medicine. What did that background reveal to you about how the pet food industry operates?
Ou: My background in pharma finance includes commercialization and supply chain. One of the biggest lessons from that environment is that quality systems are not optional. In pharma, a product doesn't move forward because we believe it's good. It only moves forward because it has met predefined specifications, and those specifications have been verified through testing.
When I started learning about pet nutrition, what struck me wasn't necessarily the quality of the ingredients. It was that the industry often places much more emphasis on ingredient stories and marketing narratives than on finished-product verification and outcome measurement. That's partly because the industry evolved differently. Pharma companies are built around validation, documentation, and release testing. Pet food companies, on the other hand, have historically competed around formulation, ingredient sourcing, palatability, and brand positioning.
dvm360: Where do you see the most meaningful gaps?
Ou: As I looked deeper, the gap that stood out most was the space between what brands claim and what they can objectively substantiate. Many companies make claims about digestibility, wellness, ingredient quality, or even health benefits, but there are often limited finished-food evaluations or validations, or even prospective outcomes data, behind those claims.
That creates a challenge for veterinarians, as veterinarians are trained to make evidence-based recommendations, which is great, and we want to rely on that. The more objective data that exist around our foods' nutritional composition, consistency, and even biological performance, the easier it is for a veterinarian to evaluate where that food fits for a patient.
dvm360: How did coming from outside veterinary medicine shape your approach?
Ou: Being an outsider, coming from pharma and not from a veterinary medicine background, was actually helpful in that process, because I wasn't carrying assumptions about how things were supposed to be done just because they have been done in a certain way for decades. I could ask simple questions like, "How do we know this batch contains what we think it contains?" or, "How do we know dogs respond the way we expect? What data support that claim?"
Those are the questions that ultimately shaped Purely Golden Foods. We didn't set out to reinvent pet food. We set out to bring more verification, transparency, and evidence generation into that process.
dvm360: What role does the veterinary nutritionist play throughout the formulation process?
Ou: For us, veterinary nutritionist oversight isn't a one-time sign-off on a recipe. It begins during formulation, where nutrient targets and ingredient specs are established. Then it continues through manufacturing reviews, finished-product nutrient testing, and ongoing reformulation decisions if needed. Our nutritionist also reviews research findings and helps translate those findings into formulation improvements. We view it as an ongoing scientific partnership rather than a one-time consultation.
dvm360: Fresh ingredients introduce variability based on source and cooking. How does Purely Golden Foods manage consistency?
Ou: You are absolutely right, because fresh ingredients truly introduce variability, and in many ways, that's one of the central challenges of working with minimally processed food. At Purely Golden Foods, we address that through 3 layers of control: ingredient qualification, process control, and finished-product verification.
The first layer is sourcing. We work with qualified suppliers and establish ingredient specifications for the raw materials we purchase. Those specs help ensure that ingredients consistently meet our expectations before they enter production. We also maintain supplier relationships that allow us to monitor changes in sourcing, ingredient quality, and availability over time.
The second layer is process control. Fresh ingredients naturally vary in moisture content, nutrient composition, and physical characteristics based upon seasonality or availability. Because of that, manufacturing cannot simply be a recipe-following exercise. Cooking temperatures, cooking times, handling procedures, cooling protocols, and ingredient incorporation steps are standardized and monitored to reduce unnecessary variation. Nutrient-sensitive components such as oils and premixes are added under controlled conditions to help preserve their nutrient integrity.
The third, and I would say the most important, layer is finished-product testing. Even with strong sourcing and manufacturing controls, variability can still occur, and that's why we believe the finished food, not just an ingredient spec sheet, is the final source of truth. Finished-product testing allows us to evaluate whether the nutritional targets were actually achieved. If there is a deviation, we can identify it and make adjustments rather than assuming the formulation performs exactly as expected.
Our philosophy is that consistency isn't achieved by eliminating variability, because that's impossible with biological ingredients. Consistency is achieved by measuring, monitoring, and managing that variability throughout the system. Ultimately, batch testing serves as the final safeguard, because it captures any variation that may not be apparent through supplier qualification or process control alone.
dvm360: How was the 8-week controlled feeding evaluation at Cornell designed?
Ou: The Cornell evaluation was designed as an 8-week controlled feeding study using healthy adult dogs, [specifically] Marshall Beagles [because] they tend to have more stable and predictable outcomes between different dogs. Our goal is not simply to confirm nutritional adequacy, but to observe how dogs respond physiologically to the finished food under controlled conditions.
The study evaluated multiple outcome categories, including body weight, body condition scores, stool quality, food intake and palatability, inflammatory biomarkers, microbiome characteristics, and other wellness measures. We wanted to look beyond formulation on paper and assess how the dogs actually respond to the diet over time.
dvm360: What did the evaluation find?
Ou: One of the most encouraging findings from this trial was digestive consistency. Dogs consuming the Purely Golden Foods diet demonstrated improvement in stool quality relative to baseline observations, while maintaining excellent food acceptance throughout the study. We also observed favorable microbiome shifts and encouraging trends in several inflammatory and wellness markers that are being further analyzed as part of the complete data package.
dvm360: Were there any unexpected findings, and how did they shape the formulation?
Ou: One unexpected observation was that some dogs initially lost more weight than anticipated after transitioning onto our diet. The dogs remained healthy, but it suggested our caloric assumptions and feeding calculations needed refinement. Rather than viewing that as a negative outcome, we view it as useful information, and that finding directly influenced our formulation and feeding approach. We reviewed caloric density, feeding recommendations, and nutrient delivery targets to ensure that body condition could be maintained while preserving the digestive benefits we were seeing. In other words, the study wasn't conducted simply to generate data. It was used as a feedback mechanism to improve the products.
More broadly, the Cornell evaluation reinforced our belief that finished-food validation matters. Ingredient lists and nutrition specifications are important, but observing how dogs respond to a complete diet provides a different level of insight.
dvm360: Do you plan to publish or share the Cornell findings with the broader veterinary community?
Ou: Absolutely. From the beginning, our intention was not simply to conduct the evaluation, but to contribute the findings back to the veterinary community. We are currently in the manuscript preparation phase and are working with our scientific collaborators to develop a publication suitable for peer review. Our goal is to submit the study to a peer-reviewed veterinary journal, and if the timeline remains on track, we hope to have that process underway by the end of this year.
Beyond journal publication, we also expect to share findings through scientific and veterinary education channels. That may include conference presentations later in the year, professional meetings, and technical summaries that allow veterinarians to evaluate the data directly.
For us, publication is a natural extension of the study. The objective wasn't simply to support a product launch. It was to generate evidence, and we wanted to learn from the results and make those findings available to clinicians who are making nutritional recommendations every day. From a longer-term perspective, we hope this is the first of multiple studies.
Read more:
dvm360: Purely Golden Foods currently focuses on dogs under 20 lb. What nutritional or physiologic considerations made small-breed dogs your focus?
Ou: We chose to focus on dogs under 20 lbs because we believe small dogs present a unique nutritional and practical challenge that is often underappreciated.
First, small dogs generally have higher energy requirements relative to their body weight than larger dogs. That means they need to maintain sufficient nutrition from a much smaller daily food intake, and small errors in formulation, caloric density, or feeding practices can therefore have a proportionally larger impact over time. Controlled feeding studies and body condition monitoring are [especially] important, because energy needs can vary considerably among individual dogs.
Second, food volume matters. Small dogs consume less food each day because they eat fewer grams of food. Nutrient delivery becomes particularly important, and the diet has to provide appropriate nutrition within a relatively small serving size.
Third, many of the concerns owners bring to veterinarians for small dogs are digestive in nature. Stool quality, digestive consistency, food tolerance, and feeding management tend to be highly visible outcomes for owners. Those were outcomes we felt we could evaluate and improve through formulation and finished-food validation.
There are also practical health considerations. Small breeds often live longer than larger breeds, meaning they may consume the same diet for well over a decade. When a dog eats thousands of meals over a lifetime, consistency and nutritional quality become increasingly important.
dvm360: Why start with 1 population rather than formulating for all dogs at launch?
Ou: Rather than trying to formulate [for] every dog immediately, we chose to concentrate on 1 population first: understand that population deeply, generate evidence, and build expertise before expanding into additional life stages, sizes, or even species.
So our decision wasn't based on the belief that small dogs are completely different animals nutritionally. It was based on the observation that they have unique feeding realities, unique owner concerns, and a need for precision because they are consuming relatively small amounts of food over very long lifespans.
dvm360: With interest in fresh food growing, what questions should veterinarians ask of any fresh food brand, including yours?
Ou: I actually think veterinarians should approach Purely Golden Foods the same way they would approach any nutrition company: Ask questions and ask for evidence. If I were a veterinarian evaluating a fresh food brand, there are several questions I would want answered.
First, who formulated the diet? Was a board-certified veterinary nutritionist involved? And if so, what role did they play? Was it a one-time consultation, or is there ongoing oversight of the formulation and manufacturing process?
Second, how is nutritional consistency verified? Is the company relying solely on formulation software, or are they performing finished-food testing? If testing is being done, how frequently is it performed, and what parameters are being measured?
The third question I would ask is: What evidence exists beyond the formulation itself? Has the company generated feeding data, conducted outcome evaluations, published research, or made study methodologies available for review?
The fourth question would be: How transparent is the company willing to be? If a veterinarian requests nutrient data, quality control information, study details, or manufacturing information, can the company prove it or provide it?
For us, the goal is to answer those questions with documentation rather than marketing language. We work with board-certified veterinary nutritionist oversight. We perform finished-product testing. We have conducted a controlled feeding evaluation and are preparing a manuscript for peer-reviewed publication. Most importantly, we believe veterinarians should be able to review the underlying information and decide for themselves.
Irene Ou is the founder of Purely Golden Foods, a Boston, Massachusetts-based fresh pet food company. She previously worked in pharmaceutical finance and supply chain at GlaxoSmithKline and Vertex Pharmaceuticals.
Related to this article









